Literature DB >> 10836649

General compliance after liver transplantation for alcoholic cirrhosis.

G A Berlakovich1, F Langer, E Freundorfer, T Windhager, S Rockenschaub, E Sporn, T Soliman, H Pokorny, R Steininger, F Mühlbacher.   

Abstract

In recent years, alcoholic cirrhosis has been accepted as an indication for OLT, compliance of patients suffering from alcoholic cirrhosis is still under discussion, however. 118 patients who had undergone OLT for alcoholic cirrhosis were considered for analysis. The mean follow-up time of the study population was 53.7 +/- 38.9 months. Compliance was defined by 3 parameters: 1. Sobriety. Fifteen (13%) out of 118 recipients suffered an alcohol relapse during the observation period. There was no difference between the groups with or without alcohol relapse concerning compliance with medication, incidence of rejection, or adherence to check-ups. 2. Drug-compliance. Nineteen recipients (16 %) were not within the target range with the immunosuppressive medication. Comparison of the compliant- and non-compliant groups produced a significant difference for late acute rejection, the other parameters being similar in the subgroups. 3. Adherence to appointments. Nearly all patients in the study population ( > 95 %) were compliant with both transplant and psychological appointments in the outpatient clinic. In conclusion, analysis of our data indicates that patients with OLT for alcoholic cirrhosis are compliant, although alcohol relapse occurs in 13 % of recipients.

Entities:  

Mesh:

Year:  2000        PMID: 10836649     DOI: 10.1007/s001470050298

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  10 in total

1.  The psychiatric diagnosis of alcohol abuse and the medical diagnosis of alcoholic related liver disease: effects on liver transplant survival.

Authors:  Anthony A Rowley; Barry A Hong; William Chapman; Jeffrey S Crippin
Journal:  J Clin Psychol Med Settings       Date:  2010-09

2.  Adherence to the medical regimen during the first two years after lung transplantation.

Authors:  Mary Amanda Dew; Andrea F Dimartini; Annette De Vito Dabbs; Rachelle Zomak; Sabina De Geest; Fabienne Dobbels; Larissa Myaskovsky; Galen E Switzer; Mark Unruh; Jennifer L Steel; Robert L Kormos; Kenneth R McCurry
Journal:  Transplantation       Date:  2008-01-27       Impact factor: 4.939

3.  Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.

Authors:  Mary Amanda Dew; Andrea F DiMartini; Jennifer Steel; Annette De Vito Dabbs; Larissa Myaskovsky; Mark Unruh; Joel Greenhouse
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

Review 4.  Long-term survival after liver transplantation for alcoholic liver disease.

Authors:  Paula Iruzubieta; Javier Crespo; Emilio Fábrega
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 5.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

Review 6.  Challenges in transplantation for alcoholic liver disease.

Authors:  Gabriela A Berlakovich
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 7.  Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.

Authors:  José Ursic-Bedoya; Stéphanie Faure; Hélène Donnadieu-Rigole; Georges-Philippe Pageaux
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis.

Authors:  Lancharat Chuncharunee; Noriyo Yamashiki; Ammarin Thakkinstian; Abhasnee Sobhonslidsuk
Journal:  BMC Gastroenterol       Date:  2019-08-22       Impact factor: 3.067

9.  A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study.

Authors:  Jérôme Dumortier; Christophe Duvoux; Laurence Dubel; Fabienne Bazin; Pauline Houssel-Debry
Journal:  Ann Transplant       Date:  2019-08-27       Impact factor: 1.530

10.  Determinants of Medication Adherence in Liver Transplant Recipients.

Authors:  Mayank Jain; Jayanthi Venkataraman; Mettu S Reddy; Mohamed Rela
Journal:  J Clin Exp Hepatol       Date:  2019-03-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.